Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 9, 2002, Pages 2747-2751

  Rolain, Jean Marc ^a   Stuhl, Laetitia ^a   Maurin, Max ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TELITHROMYCIN; THIAMPHENICOL;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; DNA SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RICKETTSIA; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; CALIBRATION; COLORING AGENTS; DNA, BACTERIAL; KINETICS; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RICKETTSIA; RICKETTSIA CONORII; RICKETTSIA FELIS; RICKETTSIA TYPHI;

EID: 0036716794     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.9.2747-2751.2002     Document Type: Article

References (23)

1. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever
2. Rickettsia felis: Molecular characterization of a new member of the spotted fever group
3. Quantification of bacterial transcripts during infection using competitive reverse transcription-PCR (RT-PCR) and LightCycler RT-PCR
4. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever
5. In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers
6. In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers
7. In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxyclarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers
8. Use of pefloxacin in the treatment of Rickettsiosis and Coxiellosis
9. Emended description of Rickettsia felis (Bouyer et al. 2001), a temperature-dependent cultured bacterium
10. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever
11. Quantitative detection of Botrelia burgdorferi by real-time PCR
12. In vitro and in vivo antibiotic susceptibilities of ELB rickettsiae
13. Ciprofloxacin therapy for Mediterranean spotted fever
14. A flea-associated Rickettsia pathogenic for humans
15. Emerging rickettsioses
16. Rickettsioses as paradigms of new or emerging infectious diseases
17. Jail fever (epidemic typhus) outbreak in Burundi
18. In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials
19. New quinolones in the treatment of Mediterranean spotted fever (MSF): A comparative study with other antibiotic regimens
20. A simple method for amplification of DNA from paraffin-embedded tissues
21. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis
22. Continuous fluorescence monitoring of rapid cycle DNA amplification
23. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control